In CRC, DDR1 expression was recently observed to be associated with more stromal infiltration, upregulation of epithelial-mesenchymal transition genes, transforming growth factor-β (TGF-β) signaling, angiogenesis, matrix remodelling pathways, and complement-mediated inflammation [5]. The gene discussed is DDR1; the disease is colorectal carcinoma.